Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on May 7, 2025
Township of Pennsauken Bids for Better with OpenGov
EIN Presswire
·
May 7, 2025
PENNSAUKEN , NJ, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Struggling with a lack of visibility into vendor engagement and a decentralized process for managing specifications, officials from Pennsauken Township in Camden County, NJ, set out to …
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
GlobeNewswire
·
May 7, 2025
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
GlobeNewswire
·
May 7, 2025
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …
MKS Instruments Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Quarterly revenue of $936 million, at the high end of guidance Quarterly GAAP net income of $52 million and net income per diluted share of $0.77, each above the midpoint of guidance Quarterly Adjusted EBITDA of $236 million, at the high end of guidance, …
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 7, 2025
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 — Streamlining operations and focusing on delivering potential value generating program milestones, with …
ESCO Reports Second Quarter Fiscal 2025 Results
GlobeNewswire
·
May 7, 2025
St. Louis, May 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2025 (Q2 2025). Operating Highlights Q2 2025 Sales increased $16.4 million (7 …
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
GlobeNewswire
·
May 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …
SiTime Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the first quarter ended March 31, 2025. Net revenue in the first quarter of 2025 was $60.3 million …
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GlobeNewswire
·
May 7, 2025
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
May 7, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
GlobeNewswire
·
May 7, 2025
TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …
Veeco Announces Over $35 Million in Advanced Packaging Lithography System Orders From IDM & OSAT Customers
GlobeNewswire
·
May 7, 2025
PLAINVIEW, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced its received over $35 million of orders for its AP300™ Lithography systems in recent quarters from a wide-range of IDM and OSAT customers. The orders …
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
May 7, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 7, 2025
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …
Fortinet Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Highlights Total revenue of $1.54 billion, up 14% year over year Product revenue of $459 million, up 12% year over year Billings of $1.60 billion, up 14% year over year1 Unified SASE ARR2 up 26% and Security Operations ARR2 up 30%, year over year Record …
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
GlobeNewswire
·
May 7, 2025
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …
LiveRamp to Discuss Fiscal 2025 Fourth Quarter and Full Year Results
GlobeNewswire
·
May 7, 2025
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), a leading data collaboration platform, today announced that its fiscal 2025 fourth quarter and full year earnings release will be issued on Wednesday, May 21, 2025 after the financial …
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …
red violet Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
BOCA RATON, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the quarter ended March 31, 2025. “We are extremely pleased to report another …